Back to Journals » OncoTargets and Therapy » Volume 12

Corrigendum

Synergistic Effect Of A Retinoid X Receptor-Selective Ligand Bexarotene And Docetaxel In Prostate Cancer [Corrigendum]

       

Authors Shen D, Wang H , Zheng Q, Cheng S, Xu L, Wang M, Li GH, Xia L

Received 17 October 2019

Accepted for publication 17 October 2019

Published 25 October 2019 Volume 2019:12 Pages 8807—8808

DOI https://doi.org/10.2147/OTT.S235000

Download Article [PDF] 


Shen D, Wang H, Zheng Q, et al. Onco Targets Ther. 2019;12:7877–7886.

 

Upon reviewing the article, the authors noticed an error in two of the authors name (page 7877). The correct author ames are Liqun Xia and Gonghui Li.

 

The authors apologize for this error.

 

Read the original article

 

Creative Commons License © 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]